Moderna, Inc. (MRNA)
140.34
+2.35
(+1.70%)
USD |
NASDAQ |
Aug 31, 16:00
137.84
-2.50
(-1.78%)
After-Hours: 05:41
Moderna Cash from Operations (TTM) : -1.073B for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.073B |
| March 31, 2026 | -1.466B |
| December 31, 2025 | -1.873B |
| September 30, 2025 | -1.978B |
| June 30, 2025 | -2.697B |
| March 31, 2025 | -3.052B |
| December 31, 2024 | -3.004B |
| September 30, 2024 | -3.207B |
| June 30, 2024 | -3.241B |
| March 31, 2024 | -2.882B |
| December 31, 2023 | -3.118B |
| September 30, 2023 | -2.078B |
| June 30, 2023 | -226.00M |
| March 31, 2023 | 993.00M |
| December 31, 2022 | 4.981B |
| September 30, 2022 | 6.629B |
| Date | Value |
|---|---|
| June 30, 2022 | 9.653B |
| March 31, 2022 | 13.41B |
| December 31, 2021 | 13.62B |
| September 30, 2021 | 11.57B |
| June 30, 2021 | 9.191B |
| March 31, 2021 | 5.104B |
| December 31, 2020 | 2.027B |
| September 30, 2020 | 664.63M |
| June 30, 2020 | -335.21M |
| March 31, 2020 | -419.92M |
| December 31, 2019 | -458.00M |
| September 30, 2019 | -450.97M |
| June 30, 2019 | -425.83M |
| March 31, 2019 | -363.75M |
| December 31, 2018 | -330.86M |
| September 30, 2018 | -342.77M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Sarepta Therapeutics, Inc. | 93.95M |
| BioNTech SE | 725.62M |
| Kailera Therapeutics, Inc. | -- |
| Twist Bioscience Corp. | -53.07M |
| Revolution Medicines, Inc. | -1.223B |